Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes

BACKGROUND: It is unclear if direct-acting oral anticoagulants (DOACs) use before hospitalization due to COVID-19 diagnosis would potentially impact the severity and clinical outcomes thereafter. We compared 30-day hospitalization/re-hospitalization and clinical outcomes between patients on chronic...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivera-Caravaca, José Miguel, Buckley, Benjamin J.R., Harrison, Stephanie L., Fazio-Eynullayeva, Elnara, Underhill, Paula, Marín, Francisco, Lip, Gregory Y.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236305/
https://www.ncbi.nlm.nih.gov/pubmed/34218058
http://dx.doi.org/10.1016/j.thromres.2021.06.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236305/
https://www.ncbi.nlm.nih.gov/pubmed/34218058
http://dx.doi.org/10.1016/j.thromres.2021.06.014

Ejemplares similares